{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:53:30Z","timestamp":1777870410791,"version":"3.51.4"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T00:00:00Z","timestamp":1394064000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s40620-014-0076-x","type":"journal-article","created":{"date-parts":[[2014,3,5]],"date-time":"2014-03-05T06:48:40Z","timestamp":1394002120000},"page":"699-706","source":"Crossref","is-referenced-by-count":21,"title":["l-Carnitine status in end-stage renal disease patients on automated peritoneal dialysis"],"prefix":"10.1093","volume":"27","author":[{"given":"Lorenzo","family":"Di Liberato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arduino","family":"Arduini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augusto","family":"Di Castelnuovo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cosima","family":"Posari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Sacchetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Urbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Bonomini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,3,6]]},"reference":[{"key":"76_CR1","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1152\/physrev.1983.63.4.1420","volume":"63","author":"J Bremer","year":"1983","unstructured":"Bremer J (1983) Carnitine-metabolism and function. Physiol Rev 63:1420\u20131480","journal-title":"Physiol Rev"},{"key":"76_CR2","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.addr.2009.04.024","volume":"61","author":"VA Zammit","year":"2009","unstructured":"Zammit VA, Ramsay RR, Bonomini M, Arduini A (2009) Carnitine mitochondrial function and therapy. Adv Drug Deliv Rev 61:1353\u20131362","journal-title":"Adv Drug Deliv Rev"},{"key":"76_CR3","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1053\/ajkd.2001.27408","volume":"38","author":"G Guarnieri","year":"2001","unstructured":"Guarnieri G, Situlin R, Biolo G (2001) Carnitine metabolism in uremia. Am J Kidney Dis 38:S63\u2013S67","journal-title":"Am J Kidney Dis"},{"key":"76_CR4","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S0272-6386(03)00110-0","volume":"41","author":"G Eknoyan","year":"2003","unstructured":"Eknoyan G, Latos DL, Lindberg J (2003) Practice recommendations for the use of l-carnitine in dialysis-related carnitine disorder. National Kidney Foundation Carnitine Consensus Conference. Am J Kidney Dis 41:868\u2013876","journal-title":"Am J Kidney Dis"},{"key":"76_CR5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000167119","volume":"6","author":"C Wanner","year":"1986","unstructured":"Wanner C, Forstner-Wanner S, Schaeffer G, Schollmeyer P, Horl WH (1986) Serum free carnitine, carnitine esters and lipids in patients on peritoneal dialysis and hemodialysis. Am J Nephrol 6:206\u2013211","journal-title":"Am J Nephrol"},{"issue":"Suppl 2","key":"76_CR6","doi-asserted-by":"crossref","first-page":"S440","DOI":"10.1177\/089686089301302S111","volume":"13","author":"T Pliakogiannis","year":"1993","unstructured":"Pliakogiannis T, Chatzidimitriou C, Evangeliou A, B\u00f6hles HJ, Kalaitzidis K (1993) Serum carnitine levels, lipid profile, and metabolic status of patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 13(Suppl 2):S440\u2013S443","journal-title":"Perit Dial Int"},{"issue":"Suppl 2","key":"76_CR7","doi-asserted-by":"crossref","first-page":"S444","DOI":"10.1177\/089686089301302S112","volume":"13","author":"C Chatzidimitriou","year":"1993","unstructured":"Chatzidimitriou C, Plikogiannis T, Evangeliou A, Tsalkidou T, B\u00f6hles HJ, Kalaitzidis K (1993) Evaluation of carnitine levels according to the peritoneal equilibration test in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 13(Suppl 2):S444\u2013S447","journal-title":"Perit Dial Int"},{"key":"76_CR8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/ki.1996.21","volume":"49","author":"D Constantin-Teodosiu","year":"1996","unstructured":"Constantin-Teodosiu D, Kirby DP, Short AH, Burden RP, Morgan AG, Greenhaff PL (1996) Free and esterified carnitine in continuous ambulatory peritoneal dialysis patients. Kidney Int 49:158\u2013162","journal-title":"Kidney Int"},{"key":"76_CR9","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1023\/A:1007127614765","volume":"31","author":"AE Gzegorzewska","year":"1999","unstructured":"Gzegorzewska AE, Mariak I, Dobrowolska-Zachwieja A (1999) Continuous laboratory peritoneal dialysis (CAPD) adequacy influences serum free carnitine level. Int Urol Nephrol 31:533\u2013540","journal-title":"Int Urol Nephrol"},{"key":"76_CR10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000168064","volume":"10","author":"BA Warady","year":"1990","unstructured":"Warady BA, Borum P, Stall C, Millspaugh J, Taggart E, Lum G (1990) Carnitine status of pediatric patients on continuous ambulatory peritoneal dialysis. Am J Nephrol 10:109\u2013114","journal-title":"Am J Nephrol"},{"key":"76_CR11","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1007\/s00467-003-1302-2","volume":"18","author":"C Kosan","year":"2003","unstructured":"Kosan C, Sever L, Arisoy N, Caliskan S, Kasapcopur \u00d6 (2003) Carnitine supplementation improves apolipoprotein B levels in pediatric peritoneal dialysis patients. Pediatr Nephrol 18:1184\u20131188","journal-title":"Pediatr Nephrol"},{"key":"76_CR12","first-page":"130","volume":"22","author":"VB Marin","year":"2006","unstructured":"Marin VB, Azocar M, Molina M, Guerrero JL, Ratner R, Cano F (2006) Total carnitine and acylated carnitine ratio: relationship of free carnitine with lipid parameters in pediatric dialysis patients. Adv Perit Dial 22:130\u2013135","journal-title":"Adv Perit Dial"},{"key":"76_CR13","first-page":"208","volume":"22","author":"A Aguilar-Kitsu","year":"2006","unstructured":"Aguilar-Kitsu A, Ibarra-Cazares P, Mendoza-Guevara L et al (2006) Frequency of low carnitine levels in children on dialysis. Adv Perit Dial 22:208\u2013210","journal-title":"Adv Perit Dial"},{"key":"76_CR14","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00467-006-0408-8","volume":"22","author":"E Verrina","year":"2007","unstructured":"Verrina E, Caruso U, Calevo MG et al (2007) Effect of carnitine supplementation on lipid profile and anemia in children on chronic dialysis. Pediatr Nephrol 22:727\u2013733","journal-title":"Pediatr Nephrol"},{"key":"76_CR15","unstructured":"Centers of Medicare & Medicaid Services (2002) Levocarnitine for use in the treatment of carnitine deficiency in ESRD patients. Transmittal AB-02-165. Department of Health and Human Services, Centers for Medicare & Medicaid Services, Baltimore."},{"key":"76_CR16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3747\/pdi.2011.00166","volume":"32","author":"WM Michels","year":"2012","unstructured":"Michels WM, Verduijn M, Parikova A et al (2012) Time course of peritoneal function in automated and continuous peritoneal dialysis. Perit Dial Int 32:605\u2013611","journal-title":"Perit Dial Int"},{"key":"76_CR17","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2215\/CJN.05720809","volume":"5","author":"K Chaundary","year":"2010","unstructured":"Chaundary K, Khanna R (2010) Biocompatible peritoneal dialysis solutions: do we have one? Clin J Am Soc Nephrol 5:723\u2013732","journal-title":"Clin J Am Soc Nephrol"},{"key":"76_CR18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1053\/j.ackd.2007.03.009","volume":"14","author":"CJ Holmes","year":"2007","unstructured":"Holmes CJ (2007) Glucotoxicity in peritoneal dialysis\u2014solutions for the solution. Adv Chronic Kidney Dis 14:269\u2013278","journal-title":"Adv Chronic Kidney Dis"},{"key":"76_CR19","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/ki.2011.117","volume":"80","author":"M Bonomini","year":"2011","unstructured":"Bonomini M, Pandolfi A, Di Liberato L et al (2011) l-Carnitine is an osmotic agent suitable for peritoneal dialysis. Kidney Int 80:645\u2013654","journal-title":"Kidney Int"},{"key":"76_CR20","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1053\/j.ajkd.2013.04.007","volume":"62","author":"M Bonomini","year":"2013","unstructured":"Bonomini M, Di Liberato L, Del Rosso G et al (2013) Effect of an l-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial. Am J Kidney Dis 62:929\u2013938","journal-title":"Am J Kidney Dis"},{"key":"76_CR21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1194\/jlr.D500026-JLR200","volume":"47","author":"D Sun","year":"2006","unstructured":"Sun D, Cree MG, Zhang X, Boersheim E, Wolfe RR (2006) Measurement of stable isotopic enrichment and concentration of long-chain acyl-carnitines in tissue by HPLC-MS. J Lipid Res 47:431\u2013439","journal-title":"J Lipid Res"},{"issue":"Suppl. 2","key":"76_CR22","first-page":"s78","volume":"10","author":"V Sirolli","year":"2012","unstructured":"Sirolli V, Rossi C, Di Castelnuovo A et al (2012) Toward personalized hemodialysis by low molecular weight amino-containing compounds: future perspective of patient metabolic fingerprint. Blood Transfus 10(Suppl. 2):s78\u2013s88","journal-title":"Blood Transfus"},{"key":"76_CR23","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s11255-012-0209-x","volume":"45","author":"B Csiky","year":"2012","unstructured":"Csiky B, Bene J, Wittmann I, Sulyok E, Melegh B (2012) Effect of hemodialysis session on the dynamics of carnitine ester profile changes in l-carnitine pretreated end-stage renal disease patients. Int Urol Nephrol 45:847\u2013855","journal-title":"Int Urol Nephrol"},{"key":"76_CR24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10863-011-9324-0","volume":"43","author":"M Wajner","year":"2011","unstructured":"Wajner M, Goodman SI (2011) Disruption of mitochondrial homeostasis in organic acidurias: insights from human and animal studies. J Bioenerg Biomembr 43:31\u201338","journal-title":"J Bioenerg Biomembr"},{"issue":"Suppl 1","key":"76_CR25","doi-asserted-by":"crossref","first-page":"S355","DOI":"10.1007\/s10545-009-9017-6","volume":"32","author":"JB Hennermann","year":"2009","unstructured":"Hennermann JB, Roloff S, Gellermann J, Gr\u00fcters A, Klein J (2009) False-positive newborn screening mimicking glutaric aciduria type I in infants with renal insufficiency. J Inherit Metab Dis 32(Suppl 1):S355\u2013S359","journal-title":"J Inherit Metab Dis"},{"key":"76_CR26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1053\/j.ajkd.2012.01.014","volume":"60","author":"ON Goek","year":"2012","unstructured":"Goek ON, D\u00f6ring A, Gieger C et al (2012) Serum metabolite concentrations and decreased GFR in the general population. Am J Kidney Dis 60:197\u2013206","journal-title":"Am J Kidney Dis"},{"key":"76_CR27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/039139880502800215","volume":"28","author":"E Gaggiotti","year":"2005","unstructured":"Gaggiotti E, Arduini A, Bonomini M et al (2005) Prevention of peritoneal sclerosis: a new proposal to substitute glucose with carnitine dialysis solution (biocompatibility testing in vitro and in rabbits). Int J Artif Organs 28:177\u2013187","journal-title":"Int J Artif Organs"},{"key":"76_CR28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/abbi.1993.1216","volume":"302","author":"RR Ramsay","year":"1993","unstructured":"Ramsay RR, Arduini A (1993) The carnitine acyltransferases and their role in modulating acyl-CoA pools. Arch Biochem Biophys 302:307\u2013314","journal-title":"Arch Biochem Biophys"},{"key":"76_CR29","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.mam.2004.06.002","volume":"25","author":"RR Ramsay","year":"2004","unstructured":"Ramsay RR, Zammit V (2004) Carnitine acyltransferases and their influence on CoA pools in health and disease. Mol Aspects Med 25:475\u2013493","journal-title":"Mol Aspects Med"},{"key":"76_CR30","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0272-6386(05)80019-8","volume":"37","author":"EP Brass","year":"2001","unstructured":"Brass EP, Adler S, Sietsema KE et al (2001) Intravenous l-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients. Am J Kidney Dis 37:1018\u20131028","journal-title":"Am J Kidney Dis"},{"key":"76_CR31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pharmthera.2008.08.008","volume":"120","author":"A Arduini","year":"2008","unstructured":"Arduini A, Bonomini M, Savica V, Amato A, Zammit V (2008) Carnitine in metabolic disease: potential for pharmacological intervention. Pharmacol Ther 120:149\u2013156","journal-title":"Pharmacol Ther"},{"key":"76_CR32","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1139\/y87-283","volume":"65","author":"JJ Hamilton","year":"1987","unstructured":"Hamilton JJ, Hahn P (1987) Carnitine and carnitine esters in rat bile and human duodenal fluid. Can J Physiol Pharmacol 65:1816\u20131820","journal-title":"Can J Physiol Pharmacol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-014-0076-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-014-0076-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-014-0076-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:57:46Z","timestamp":1777564666000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/27\/6\/699\/8372179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["76"],"URL":"https:\/\/doi.org\/10.1007\/s40620-014-0076-x","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,6]]}}}